Archive - August 2004

• Concurrent chemotherapy and radiotherapy improves survival (31/08/2004)
• Weekly docetaxel in metastatic breast cancer (31/08/2004)
• ASCO recommendations in stage II colon cancer (31/08/2004)
• No evidence for adjuvant therapy in stage II colon cancer (30/08/2004)
• Unfair dismissals now salary capped (30/08/2004)
• I-Can-Survive workshops for patients (30/08/2004)
• Drive through pharmacy "a rubbish idea" - MO News (30/08/2004)
• New agents improve survival (27/08/2004)
• Adjuvant chemotherapy improves survival compared to surgery alone in resectable NSCLC (27/08/2004)
• Excess enthusiasm for colonoscopic surveillance after polypectomy (27/08/2004)
• Pros and cons of email consultations (26/08/2004)
• Physical Quality of Life measures predict survival (24/08/2004)
• Caregivers and patients in cancer pain management (24/08/2004)
• Majority of GPs prescribe off-label for patients - MO News (23/08/2004)
• Rates of surgery in indigenous people (20/08/2004)
• Circulating tumour cells predict survival (20/08/2004)
• Inpatient efficiencies improved by 'hospitalist' doctor care (19/08/2004)
• Prognostic factors in thin melanoma (19/08/2004)
• Sequential doxorubicin and docetaxel (19/08/2004)
• Limited duration of chemotherapy benefit (17/08/2004)
• Increased response to taxane chemotherapy in HER-2/neu positive breast cancer (17/08/2004)
• No benefit for interferon alpha maintenance therapy (17/08/2004)
• Health insurance commission statistical reporting for healthcare providers (16/08/2004)
• Patients like being involved in teaching sessions (16/08/2004)
• The importance of drug interactions in oncology (16/08/2004)
Displaying results 1-25 (of 45)
 |<  < 1 - 2  >  >| 

Back to archive ...